| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
|
9,667 |
6,271 |
$730K |
| 99214 |
|
2,365 |
1,848 |
$246K |
| 99396 |
|
513 |
513 |
$55K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
302 |
293 |
$19K |
| 90756 |
|
491 |
488 |
$14K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
302 |
293 |
$6K |
| 93000 |
|
503 |
498 |
$6K |
| 90471 |
|
705 |
689 |
$6K |
| 76700 |
|
47 |
47 |
$4K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
238 |
232 |
$2K |
| 36415 |
|
1,778 |
1,743 |
$2K |
| 93975 |
|
14 |
14 |
$2K |
| 90661 |
|
47 |
47 |
$1K |
| 99442 |
|
17 |
16 |
$1K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
277 |
268 |
$1K |
| 90714 |
|
39 |
38 |
$1K |
| 90688 |
|
63 |
62 |
$1K |
| G0008 |
Administration of influenza virus vaccine |
139 |
137 |
$1K |
| 76856 |
|
12 |
12 |
$718.44 |
| 81002 |
|
265 |
263 |
$473.01 |
| G9275 |
Documentation that patient is a current non-tobacco user |
13 |
13 |
$0.00 |
| 76770 |
|
13 |
13 |
$0.00 |